期刊
JOURNAL OF CONTROLLED RELEASE
卷 334, 期 -, 页码 353-366出版社
ELSEVIER
DOI: 10.1016/j.jconrel.2021.04.026
关键词
Colon-targeted drug delivery; Micro/nanoparticulate systems; Inflammatory bowel disease; Ulcerative colitis; Crohn's disease; Colorectal cancer; Oral administration; Polysaccharides
资金
- National Council for Scientific and Technological Development (CNPq, Brazil) [408244/20186, 465687/2014-8]
- Sao Paulo Research Foundation (FAPESP) [2016/014649, 2019/198173, 2019/10761-5]
- Coordination for the Improvement of HigherLevel Personnel (CAPES)
- Sao Paulo Research Foundation (FAPESP, Brazil) [2014/509282]
Colon-targeted oral drug delivery is a promising approach for treating intestinal diseases, though it faces challenges that require advanced strategies and the use of micro- and nanoparticles for localized therapy. Polysaccharides-based nano-in-microparticulate systems have key properties and advantages for effective colon-specific oral delivery, showing potential for targeted therapy within the colon.
Colon-targeted oral delivery of drugs remains as an appealing and promising approach for the treatment of prevalent intestinal diseases (ID), such as inflammatory bowel disease (IBD) and colorectal cancer (CRC). Notwithstanding, there are numerous challenges to effective drug delivery to the colon, which requires the design of advanced strategies. Micro- and nanoparticles have received great attention as colon-targeted delivery platforms due to their reduced size and structural composition that favors the accumulation and/or residence time of drugs at the site of action and/or absorption, contributing to localized therapy. The choice by natural polysaccharides imparts key properties and advantages to the nano-in-microparticulate systems to effective colon-specific oral delivery. This review proposes to discuss the physiological barriers imposed by the gastrointestinal tract (GIT) against oral administration of drugs, as well as pathological factors and challenges of the ID for oral delivery of colon-targeted systems. We then provide an updated progress about polysaccharides-based colon-targeted drug delivery systems, including microparticulate, nanoparticulate and nano-in-microparticulate systems, highlighting their key properties, advantages and limitations to achieving targeted delivery and efficacious therapy within the colon. Lastly, we provide future perspectives, towards advances in the field and clinical translation of colon-targeted oral delivery systems for ID therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据